- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
TheStreet's Adam Feuerstein answers reader questions about biotech stocks.
A sale or spinoff of this business will likely get the attention of competitors that want to increase their over-the-counter product units.
European bond markets hit hard as traders brace for inflation rise, blunting two-day 'Trump rally'.